Skip to Main Content

Paper Details

Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups.
Nature
201
2019
ER, ER-positive genomic, ER-positive genomic subgroups, PAM50, breast cancer, breast-cancer, cancer, human, human epidermal, immunohistochemical, immunohistochemical subtype, immunohistochemical subtypes, oestrogen, oestrogen-receptor, patient, patients, triple-negative breast cancers, tumour, tumours
Author NameAffiliation
Oscar M RuedaCancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge
Stephen-John SammutCancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge
Jose A SeoaneStanford University School of Medicine
Jose A SeoaneStanford University School of Medicine
Jose A SeoaneStanford Cancer Institute, Stanford University School of Medicine
Alejandra BrunaCancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge
Paul D P PharoahCancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahNIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospital NHS Foundation Trust
Paul D P PharoahAddenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust
Paul D P PharoahCancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge
Paul D P PharoahAddenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust
Paul D P PharoahNIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospital NHS Foundation Trust
Paul D P PharoahUniversity of Cambridge
Samuel AparicioBritish Columbia Cancer Research Centre
Carlos CaldasCancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge
Carlos CaldasAddenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust
Carlos CaldasNIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospital NHS Foundation Trust
Christina CurtisStanford University School of Medicine
Christina CurtisStanford University School of Medicine
Christina CurtisStanford Cancer Institute, Stanford University School of Medicine
  • 1 - 21

Datasets